COLOSIMO, Carlo
 Distribuzione geografica
Continente #
NA - Nord America 4.329
EU - Europa 1.005
AS - Asia 708
AF - Africa 81
OC - Oceania 30
SA - Sud America 23
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.179
Nazione #
US - Stati Uniti d'America 4.305
IT - Italia 300
SG - Singapore 295
SE - Svezia 191
IN - India 190
CN - Cina 185
FI - Finlandia 137
UA - Ucraina 104
DE - Germania 78
TG - Togo 77
GB - Regno Unito 36
BG - Bulgaria 35
AU - Australia 29
RU - Federazione Russa 25
IE - Irlanda 24
CA - Canada 23
AR - Argentina 18
FR - Francia 18
RO - Romania 15
IR - Iran 12
BE - Belgio 11
KR - Corea 11
CH - Svizzera 9
ES - Italia 6
NL - Olanda 6
PT - Portogallo 5
TR - Turchia 4
EU - Europa 3
BR - Brasile 2
CL - Cile 2
CZ - Repubblica Ceca 2
ID - Indonesia 2
PK - Pakistan 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
CO - Colombia 1
DK - Danimarca 1
IL - Israele 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MA - Marocco 1
MX - Messico 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
SC - Seychelles 1
TW - Taiwan 1
Totale 6.179
Città #
Fairfield 728
Ashburn 333
Woodbridge 328
Houston 287
Chandler 286
Seattle 267
Cambridge 248
Singapore 230
Wilmington 208
Ann Arbor 197
Princeton 113
Santa Clara 102
Plano 99
San Paolo di Civitate 85
Rome 84
Lomé 77
Dearborn 75
Beijing 70
Boston 69
Lawrence 59
San Diego 50
Helsinki 43
Millbury 42
Jacksonville 40
New York 39
Andover 33
Sofia 33
Norwalk 27
Sydney 27
Dublin 24
Fremont 22
Federal 17
Falkenstein 16
Boardman 15
Cagliari 14
Hefei 14
Toronto 13
Des Moines 12
Dallas 11
Falls Church 11
Kunming 11
Brussels 9
Moscow 9
Bern 8
Guangzhou 8
Jinan 8
Ottawa 8
San Mateo 8
London 7
Nanjing 7
Southend 7
Bühl 6
Council Bluffs 6
Leawood 6
Milan 5
Seongnam 5
Dixon 4
Grafing 4
Indiana 4
Istanbul 4
Los Angeles 4
Paris 4
Putney 4
Shanghai 4
Besana In Brianza 3
Bremen 3
Capaccio 3
Giugliano In Campania 3
Mannheim 3
Nanchang 3
Naples 3
Pune 3
Redmond 3
Shenyang 3
Venezia 3
Auburn Hills 2
Avellino 2
Boa Vista 2
Bolzano 2
Brno 2
Buffalo 2
Coimbra 2
Frankfurt am Main 2
Fuengirola 2
Fuzhou 2
Hebei 2
Hyderabad 2
Islamabad 2
Jakarta 2
Kashan 2
Laurel 2
Montréal 2
Muizenberg 2
Nürnberg 2
Philadelphia 2
Phoenix 2
Sagrado 2
San Francisco 2
Serrenti 2
Shaoxing 2
Totale 4.681
Nome #
Frequency and clinical features of GBA mutations in Italian patients with Parkinson disease 151
Craniocervical dystonia: clinical and pathophysiological features 149
Corticobasal syndrome: neuroimaging and neurophysiological advances 116
Epidemiology of multiple system atrophy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms 108
Fast voluntary neck movements in patients with cervical dystonia: A kinematic study before and after therapy with botulinum toxin type A 105
Abnormal salivary total and oligomeric alpha-synuclein in Parkinson's disease 101
A comparative study of primary and secondary hemifacial spasm 99
Psychiatric disturbances in patients with progressive supranuclear palsy: a case-control study. 90
Cardiovascular dysfunction in untreated Parkinson's disease: A multi-modality assessment 89
Mri gray and white matter measures in progressive supranuclear palsy and corticobasal syndrome 89
Hedonistic homeostatic dysregulation in Parkinson's disease: a short screening questionnaire 88
An Early Image of Hemifacial Spasm: Edouard Brissaud Contribution 87
A Transverse and Longitudinal MR Imaging Voxel-Based Morphometry Study in Patients with Primary Cervical Dystonia 87
Sad and happy facial emotion recognition impairment in progressive supranuclear palsy in comparison with Parkinson's disease 84
Neutralizing Antibody and Botulinum Toxin Therapy: A Systematic Review and Meta-analysis 84
Constipation: an emerging risk factor for Parkinson's disease? 84
Abnormal Cortical Synaptic Plasticity in Primary Motor Area in Progressive Supranuclear Palsy 82
Spread of muscle spasms in hemifacial spasm 80
The role of subcutaneous infusion of apomorphine in Parkinson's disease 79
Supine hypertension in Parkinson’s disease and multiple system atrophy 79
A Further Case of Nicotine Sensitivity in Multiple System Atrophy 78
Primary motor cortex long-term plasticity in multiple system atrophy 77
Blinking in patients with clinically probable multiple system atrophy 75
Reduced dopamine in peripheral blood lymphocytes in Parkinson's disease 74
Task Force Report on Scales to Assess Dyskinesia in Parkinson's Disease: Critique and Recommendations 73
Voluntary, spontaneous and reflex blinking in patients with clinically probable progressive supranuclear palsy 73
Amantadine in parkinsonian patients unresponsive to levodopa: a pilot study 73
Clinical differential diagnosis of Parkinsonism 72
Axial motor clues to identify atypical parkinsonism. a multicentre european cohort study 72
Camptocormia in Parkinson disease: an epidemiological and clinical study 71
Bladder symptoms assessed with overactive bladder questionnaire in Parkinson's disease 71
Frontal assessment battery scores and non-motor symptoms in parkinsonian disorders 70
Psychosis associated to Parkinson's disease in the early stages: relevance of cognitive decline and depression 69
Dopamine transporter immunoreactivity in peripheral blood lymphocytes in Parkinson's disease 69
Red flags for multiple system atrophy 68
EFNS/MDS-ES recommendations for the diagnosis of Parkinson's disease 68
Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson’s disease. 68
Apraxia of eyelid opening in a case of atypical corticobasal degeneration 67
Excessive Daytime Sleepiness in Multiple System Atrophy (SLEEMSA Study) 67
Health-related quality of life in multiple system atrophy 67
Dopaminergic system in peripheral blood mononuclear cells in Parkinson's disease 66
Yawning in Parkinson's disease. 65
Somatosensory temporal discrimination tested in patients receiving botulinum toxin injection for cervical dystonia 65
Nonmotor symptoms in adult-onset focal dystonia: psychiatric abnormalities 65
Psychiatric disorders in adult-onset focal dystonia: a case-control study 63
The European Multiple System Atrophy-Study Group (EMSA-SG) 62
Clinical diagnosis of multiple system atrophy: level of agreement between Quinn's criteria and the consensus conference guidelines. 62
null 62
Fifty years of progressive supranuclear palsy 61
null 61
Efficacy and Safety of Long-term Botulinum Toxin Treatment in Craniocervical Dystonia: A Systematic Review 60
The potential prognostic role of cardiovascular autonomic failure in α-synucleinopathies. 60
The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life 60
Effect of camptocormia on lung volumes in Parkinson's disease 60
Dyskinesias and motor symptoms onset in Parkinson disease. 59
Which model of stroke unit is better for stroke patient management? 59
Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study 59
Tremor in primary adult-onset dystonia: prevalence and associated clinical features 58
Psychiatric disorders in adult onset focal dystonia 57
The PRIAMO study: background, methods and recruitment 57
No association between essential tremor and migraine: A case-control study 56
Detecting nocturnal hypertension in Parkinson's disease and multiple system atrophy: proposal of a decision-support algorithm 56
A Stroke Unit in the emergency department: the first eight months of activity. 54
Circadian, circaseptan and circannual variations of the thrombolytic treatment in acute ischemic stroke. 54
CLINICAL PHENOMENOLOGY OF DYSTONIA 51
Treatment of essential tremor: a systematic review of evidence and recommendations from the Italian Movement Disorders Association 51
null 51
null 49
Admission screening for ischemic heart disease in a Stroke Unit located in an emergency department. 49
null 48
A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. European Study Group on Atypical Parkinsonism. 47
Thrombolysis in hemiballism: Is it a rational choice? 45
null 44
No increase of serum autoantibodies during therapy with recombinant human interferon-beta1a in relapsing-remitting multiple sclerosis. 44
The natural history of multiple system atrophy: a prospective European cohort study. 43
Epidemiology of progressive supranuclear palsy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms 43
Efficacy of acute ischemic stroke patients management in an emergency department stroke unit (EDSU). 43
Acute ischemic stroke: diagnostic-therapeutic procedures. The point of view of neurologists. 42
The PRIAMO Study: a multicentric assessment of non-motor symptoms and their impact on quality of life in Parkinson's disease. 42
ON BEHALF OF THE EMSA‐SG. PRESENTATION, DIAGNOSIS, AND MANAGEMENT OF MULTIPLE SYSTEM ATROPHY IN EUROPE: FINAL ANALYSIS OF THE EUROPEAN MULTIPLE SYSTEM ATROPHY REGISTRY. 41
Causes of early or late hospital referral of stroke patients. The experience of a Stroke Unit located in an emergency department. 40
Antithrombotic therapies before stroke in patients with atrial fibrillation. The experience of a Stroke Unit located in an emergency department. 39
null 37
ADMISSION SCREENING FOR ISCHEMIC EARTH DISEASE IN A STROKE UNIT LOCATED IN AN EMERGENCY DEPARTMENT. THE EAST ROME STROKE UNIT (EROSS) 37
A new score predicting intraprocedural risk in patients undergoing CT-guided percutaneous needle pulmonary biopsy (CATH-score) 37
Role of cardiac adrenergic function assessed by 123-I-MIBG in newly diagnosed parkinsonism patients 34
Early distinction of Parkinsonian-variant multiple system atrophy from Parkinson’s disease 34
Off label thrombolysis in a case of ischemic hemiballism: a case report. 33
Investigational drugs. 31
Antithrombotic therapies before stroke in patients with atrial fibrillation. The East Rome Stroke Study (EROSS). 30
Frequency of aortic and cardiac morphological abnormalities in patients with spontaneous cervical artery dissection. 30
Parasympathetic dysfunction predicts loss of nocturnal blood pressure fall in Parkinson’s Disease and Multiple System Atrophy 28
Off-label thrombolysis in a case of ischemic hemiballism: a case report. 28
Thrombolysis patients with NIHSS 0 at 24 hours: TIA or reverted stroke? 27
Usefulness of transesophageal echocardiography in early etiopathogenic classification of acute ischaemic stroke patients. 26
Direct genetic evidence for involvement of tau in progressive supranuclear palsy. European Study Group on Atypical Parkinsonism Consortium. 26
Fase dell'assistenza in emergenza-urgenza 25
Smoking habits in multiple system atrophy and progressive supranuclear palsy. European Study Group on Atypical Parkinsonisms. 23
Safe Implementation of Thrombolysis In Stroke (SITS). 21
Tha tau gene in progressive supranuclear palsy: exclusion of mutations in coding exons and exon 10 splice sites, and identification of a new intronic variant of the disease-associated H1 haplotype in italian cases 19
Totale 6.132
Categoria #
all - tutte 17.092
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.092


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020953 0 0 0 0 0 215 209 182 155 91 67 34
2020/2021416 45 64 14 36 13 32 12 46 59 60 32 3
2021/20221.030 14 77 110 25 127 27 29 108 71 79 143 220
2022/20231.056 213 297 55 88 104 116 15 58 80 7 17 6
2023/2024487 43 70 14 37 23 81 8 29 7 48 75 52
2024/2025547 46 171 63 55 80 132 0 0 0 0 0 0
Totale 6.328